scorpion
well
known
danger
sting
result
sever
consequ
human
be
includ
death
neurotoxin
present
venom
respons
toxic
due
medic
relev
toxin
drive
forc
scorpion
natur
compound
research
field
hand
thousand
year
scorpion
venom
appli
tradit
medicin
mainli
asia
africa
remark
growth
number
character
scorpion
venom
compon
sever
drug
candid
found
potenti
tackl
mani
emerg
global
medic
threat
scorpion
becom
valuabl
sourc
biolog
activ
molecul
novel
antibiot
potenti
anticanc
therapeut
venom
compon
drawn
attent
use
scaffold
develop
drug
review
summar
promis
candid
drug
develop
isol
scorpion
venom
scorpion
constitut
well
adapt
order
predatori
anim
live
earth
nearli
million
year
poli
inhabit
virtual
everi
terrestri
habitat
except
antarctica
speci
describ
date
stockmann
ythier
key
success
product
potent
venom
use
primarili
kill
paralyz
prey
deter
possibl
competitor
predat
expans
human
civil
growth
human
popul
led
increas
interact
arthropod
frequent
result
accid
peopl
get
stung
chippaux
goyffon
immedi
pain
sting
elicit
devast
consequ
envenom
ultim
caus
human
be
credit
bad
reput
anim
effect
scorpion
sting
vari
wide
local
pain
inflamm
sever
clinic
complic
includ
death
sever
scorpion
envenom
relat
presenc
neurotoxin
venom
see
recent
review
quinterohernandez
et
al
block
modifi
function
target
ion
channel
excit
cell
result
autonom
excit
scorpion
atoxin
caus
massiv
endogen
releas
catecholamin
combin
sympathet
excit
releas
catecholamin
plasma
gener
cascad
physiolog
event
progress
arteri
hypertens
hypotens
tachycardia
bradycardia
arrhythmia
unconsci
pulmonari
edema
heart
failur
death
isbist
bawaskar
scorpion
repres
major
health
problem
sever
countri
million
scorpion
sting
regist
global
everi
year
despit
fact
scorpion
speci
known
danger
human
sting
per
year
fatal
chippaux
scorpion
side
use
tradit
medicin
sinc
emerg
ancient
cultur
mainli
asia
africa
goudet
et
al
shao
et
al
scorpion
bodi
part
venom
claim
effect
treatment
mani
condit
includ
cancer
da
gupta
et
al
diazgarcia
et
al
goudet
et
al
advent
novel
methodolog
massiv
studi
character
venom
compon
becom
evid
along
toxin
mani
peptid
present
scorpion
venom
sever
peptid
biolog
activ
proven
valuabl
tool
develop
drug
treatment
mani
import
diseas
scorpion
venom
highli
complex
mixtur
peptid
enzym
mucoprotein
free
amino
acid
nucleotid
lipid
amin
heterocycl
compon
inorgan
salt
probabl
unknown
substanc
toxin
thoroughli
studi
scorpion
venom
compon
due
pharmacolog
action
ion
channel
clinic
relev
neurotoxin
disulfidebridg
peptid
significantli
constrain
structur
toxin
act
sodium
channel
relev
effect
mammal
includ
human
classifi
two
main
type
atoxin
delay
voltageg
na
channel
inactiv
btoxin
trigger
open
channel
neg
potenti
rodriguez
de
la
vega
possani
low
dose
atoxin
provok
strong
depolar
cell
membran
follow
drop
excit
higher
dose
prolong
action
potenti
excit
cell
induc
paralysi
cardiac
arrhythmia
bosman
tytgat
action
btoxin
result
myoclon
spastic
muscular
respons
chippaux
character
scorpion
toxin
act
potassium
chlorin
calcium
channel
though
display
synergist
action
lead
clinic
manifest
role
human
envenom
seem
subsidiari
toxin
toxinrel
scorpion
venom
compon
best
known
deleteri
effect
cell
tissu
organ
paradox
shown
display
activ
might
relev
develop
pharmaceut
drug
includ
antimicrobi
antimalari
immunosuppress
anticanc
activ
among
compon
present
scorpion
venom
nondisulfidebridg
peptid
ndbp
zeng
et
al
zeng
et
al
ndbp
group
repres
major
compon
scorpion
venom
massfingerprint
studi
involv
whole
venom
consist
shown
low
molecular
weight
peptid
repres
third
molecular
weight
determin
rodriguez
de
la
sinc
main
research
interest
usual
shift
toward
higher
molecular
weight
peptid
toxic
venom
fraction
discoveri
rate
ndbp
lag
till
last
decad
compar
avail
inform
toxin
find
ndbp
exhibit
relev
biolog
activ
drawn
signific
attent
research
togeth
avail
molecular
biolog
techniqu
cdna
librari
construct
heterolog
express
late
rnaseq
result
increas
avail
inform
small
peptid
still
sever
hundr
toxin
isol
scorpion
venom
describ
dozen
ndbp
character
thu
far
almaaytah
albala
venom
compon
belong
de
ndbp
group
small
amino
acidslong
peptid
divers
sequenc
cation
display
remark
structur
flexibl
exist
random
coil
conform
aqueou
solut
readili
adopt
amphipath
ahel
structur
place
membran
mimick
environ
aqueou
trifluoroethanol
tfe
posit
charg
ndbp
easili
interact
neg
charg
lipid
head
group
biolog
membran
membran
adhes
process
drive
format
amphipath
helix
insert
hydrophob
residu
membran
lead
display
activ
huang
et
al
mechan
specif
molecular
target
result
broad
spectrum
biolog
target
sever
ndbp
exhibit
multifunct
activ
regardless
target
cell
stand
sharp
contrast
mechan
toxin
action
sinc
toxin
target
specif
receptor
ion
channel
specif
biolog
target
sever
relev
activ
describ
character
scorpion
venom
ndbp
includ
antibacteri
antifung
cytolyt
antivir
antimalari
anticanc
bradykinin
potenti
immunomodul
activ
almaaytah
albala
discoveri
put
ndbp
interest
promis
candid
therapeut
drug
hereaft
describ
divers
activ
report
scorpion
venom
compon
could
relev
design
develop
new
pharmacolog
drug
molecul
constitut
signific
promis
candid
particularli
cover
emerg
bacteria
resist
avail
antibiot
repres
firstlin
problem
world
health
system
sever
pathogen
sensibl
antibiot
rapidli
becom
multiresist
divers
bacteri
mechan
respons
appear
multiresist
includ
rapid
gener
rate
chromosom
mutat
acquisit
extrachromosom
mobil
dna
element
bacteria
surround
togeth
intrins
mechan
confer
capac
expel
antibiot
cell
alekshun
levi
multiresist
organ
emerg
spread
human
popul
sever
compromis
treatment
infect
thu
provok
public
health
crise
reduc
longterm
therapeut
valu
mani
classic
antibiot
forc
search
new
antimicrobi
candid
abl
cope
bacteri
mechan
drug
resist
gould
bal
antimicrobi
peptid
amp
found
divers
rang
phyla
bacteria
mammal
includ
human
maroti
et
al
alreadi
describ
wang
et
al
multicellular
organ
constitut
primit
conserv
compon
innat
immun
system
function
first
barrier
mani
pathogen
thank
broad
spectrum
activ
target
rapid
action
low
potenti
induc
resist
amp
becom
promis
prospect
new
antibiot
huang
et
al
mookherje
hancock
kill
microb
mainli
membranetarget
poreform
mechan
inher
difficult
microb
circumv
develop
resist
hancock
sahl
signific
fraction
function
character
scorpion
venom
ndbp
display
antimicrobi
activ
consid
amp
almaaytah
albala
harrison
et
al
clear
present
scorpion
venom
could
play
synergist
role
facilit
venom
activ
part
antimicrobi
respons
within
venom
gland
kuhnnentwig
pair
venom
gland
present
last
postabdomin
segment
telson
scorpion
open
commun
environ
facilit
contamin
saprophyt
organ
soil
thu
scorpion
expect
possess
mean
defend
microorgan
present
environ
first
amp
found
scorpion
venom
hadrurin
hadruru
aztecu
renam
hadruru
gertschi
torreslario
et
al
scorpin
cond
et
al
pandinin
pandinu
imper
isct
opisthacanthu
madagascariensi
dai
et
al
opistoporin
opistophtalmu
carinatu
parabutoporin
parabuthu
schlechteri
main
drawback
amp
gener
frequent
cytotox
eukaryot
cell
limit
clinic
applic
problem
share
scorpion
amp
mani
scorpion
ndbp
potenti
therapeut
concentr
minimum
inhibitori
concentr
mic
test
microorgan
close
concentr
cytotox
mammalian
cell
usual
measur
erythrocyt
hemolysi
assay
exampl
hadrurin
first
scorpion
ndbp
shown
display
antibacteri
activ
abl
inhibit
growth
gramposit
gramneg
bacteria
mic
mm
also
highli
hemolyt
human
erythrocyt
mm
torreslario
et
al
antimicrobialhemolyt
dualiti
repeat
almost
scorpion
amp
describ
date
reason
first
propos
prospect
antimicrobi
topic
applic
zeng
et
al
nevertheless
ndbp
show
rel
mild
cytotox
effect
improv
therapeut
index
ratio
given
toxic
dose
divid
therapeut
dose
first
exampl
effect
inhibit
growth
gramposit
bacteria
mic
mm
keep
hemolysi
low
concentr
mm
essay
sheep
erythrocyt
bmkbpp
multifunct
peptid
scorpion
mesobuthu
martensii
karsch
antimicrobi
immuneregulatori
bradykininpotenti
activ
see
bmkbpp
demonstr
strong
antimicrobi
activ
gramneg
bacteria
mic
rang
mm
also
activ
gramposit
bacteria
higher
mic
hemolyt
activ
consid
mild
hemolysi
human
erythrocyt
rel
high
mm
concentr
zeng
et
al
antimicrobi
peptid
synthes
precursor
dna
sequenc
found
cdna
librari
vaejovi
mexicanu
smithi
effect
gramposit
gramneg
bacteria
mic
mm
show
mild
hemolysi
human
erythrocyt
even
higher
concentr
mm
ramirezcarreto
et
al
recent
character
scorpion
p
imper
cdna
clone
strategi
activ
gramposit
bacteria
mic
mm
show
hemolysi
mic
mild
hemolysi
higher
concentr
mm
human
erythrocyt
zeng
et
al
three
exampl
demonstr
natur
scorpion
amp
found
good
therapeut
index
good
candid
antimicrobi
drug
develop
remain
amp
found
scorpion
venom
hemolysi
activ
assay
report
highli
hemotox
mean
valuabl
search
altern
antibiot
sever
studi
shown
potenti
amp
clinic
applic
optim
improv
antimicrobi
activ
reduc
toxic
human
cell
fjell
et
al
huang
et
al
also
demonstr
scorpion
amp
analog
natur
scorpion
amp
could
potenti
antiinfect
drug
even
treat
antibioticresist
pathogen
mucroporin
antimicrobi
peptid
synthes
sequenc
found
cdna
librari
lycha
mucronatu
moder
effect
gramposit
bacteri
strain
includ
clinic
isol
pathogen
engin
peptid
design
sequenc
mucroporin
replac
amino
acid
residu
hydrophil
side
predict
ahelix
posit
charg
residu
show
improv
antibacteri
activ
gramposit
bacteria
gramneg
bacteria
clinic
isol
antibioticresist
pathogen
includ
methicillinresist
staphylococcu
aureu
mrsa
methicillinresist
coagulaseneg
staphylococcu
mrcn
penicillinresist
aureu
prsa
penicillinresist
staphylococcu
epidermidi
prse
dai
et
al
group
appli
similar
approach
produc
potent
variant
antimicrobi
peptid
deriv
venom
scorpion
martensii
karsch
zeng
et
al
variant
show
increas
inhibitori
activ
gramneg
gramposit
bacteria
even
effect
clinic
antibioticresist
strain
mrsa
mrcn
prsa
prse
origin
hemolyt
activ
also
significantli
improv
hc
valu
wildtyp
peptid
mgml
drastic
decreas
mutant
peptid
mgml
even
relev
aureu
mous
skin
infect
model
topic
applic
effect
protect
skin
mice
infect
two
exampl
demonstr
nativ
scorpion
amp
also
effect
use
scaffold
design
potent
specif
antibiot
contrari
classic
antibiot
ligandindepend
mechan
bactericid
action
amp
impli
like
effect
clinic
strain
antibioticresist
multiresist
pathogen
within
scorpion
amp
capac
demonstr
variant
mention
follow
one
imcroporin
deriv
cdna
librari
scorpion
isometru
macul
first
peptid
scorpion
venom
origin
show
potent
antimicrobi
activ
antibiot
resist
gramposit
pathogen
strain
mrsa
mrcn
prse
mic
imcroporin
prse
mgml
lower
penicillin
g
mrsa
mrcn
strain
also
mgml
twoand
eightfold
lower
mic
cefotaxim
respect
significantli
vivo
activ
imcroporin
also
demonstr
mous
model
infect
aureu
mgkg
dose
imcroporin
abl
cope
ld
intraperiton
inject
bacteria
surviv
ratio
result
equival
use
dose
vancomycin
zhao
et
al
ctriporin
potent
antimicrobi
peptid
identifi
cdna
librari
chaerilu
tricostatu
ctriporin
effect
mrsa
mic
mg
ml
time
better
penicillin
g
time
better
cefotaxim
prse
mic
mgml
time
effect
penicillin
g
ctriporin
effect
use
topic
antibiot
treatment
aureu
mous
skin
wound
infect
model
fan
et
al
vejovin
antimicrobi
peptid
purifi
venom
scorpion
v
mexicanu
smithi
vejovin
inhibit
growth
clinic
isol
gramneg
multidrug
resist
strain
escherichia
coli
enterobact
cloaca
klebsiella
pneumonia
pseudomona
aeruginosa
acinetobact
baumanii
mic
mm
peptid
also
display
hemolyt
activ
human
erythrocyt
hc
mm
hernandezapont
et
al
recent
use
ration
approach
sever
variant
design
use
vejovin
homolog
hadrurin
templat
aim
improv
antimicrobi
hemolyt
properti
inde
variant
result
potent
parent
peptid
gramneg
multidrug
resist
strain
mic
mm
also
less
hemolyt
hc
mm
repres
dramat
improv
therapeut
index
sanchezvasquez
et
al
work
constitut
encourag
exampl
result
achiev
ration
design
novel
prospect
antimicrobi
peptid
potenti
clinic
applic
use
natur
scorpion
amp
scaffold
recent
demonstr
amp
could
combin
classic
antibiot
obtain
addit
even
synergist
effect
inhibit
bacteri
growth
find
open
new
window
opportun
clinic
applic
mix
formul
commerci
antibiot
amp
possibl
employ
low
concentr
fast
kill
amp
circumv
cytotox
mammalian
cell
togeth
commerci
antibiot
attract
thoroughli
explor
futur
infect
opportunist
fungal
pathogen
becom
major
clinic
problem
past
decad
increas
morbid
mortal
mani
immunocompromis
patient
highli
suscept
fungal
infect
transplant
recipi
immunosuppress
therapi
cancer
patient
treat
cytotox
drug
aid
patient
import
fungal
pathogen
yeast
genu
candida
cryptococcu
neoforman
mold
aspergillu
fumigatu
infect
caus
fungi
rang
superfici
mucos
infect
like
oral
candidiasi
lifethreaten
system
infect
dissemin
candidiasi
cryptococc
mening
invas
aspergillosi
sternberg
fungi
becom
resist
antifung
drug
specif
mechan
gener
one
eg
activ
transport
cell
multidrug
efflux
pump
morschhaus
thu
relev
find
new
candid
antifung
drug
cope
resist
mechan
sever
scorpion
ndbp
test
antifung
activ
activ
pathogen
clinic
import
opistoporin
parabutoporin
inhibit
growth
ic
yeast
saccharomyc
cerevisia
murphi
kavanagh
concentr
mm
inhibit
growth
candida
albican
pfaller
diekema
mic
mm
meucin
activ
fumigatu
rinaldi
c
albican
cerevisia
lethal
concentr
c
l
mm
mm
mm
respect
gao
et
al
ctriporin
effect
c
albican
mic
mgml
fan
et
al
inhibit
growth
candida
tropicali
chai
et
al
mic
mm
mm
mm
respect
zeng
et
al
modifi
peptid
androctonu
amoreuxi
effect
c
albican
mic
mm
time
potent
parent
peptid
anoth
exampl
possibl
peptid
engin
improv
amp
qualiti
almaaytah
et
al
billion
peopl
risk
malaria
endem
hundr
countri
children
subsaharan
africa
southeast
asia
highest
risk
contract
die
malaria
murray
et
al
global
morbid
mortal
malaria
decreas
substanti
last
year
still
roughli
peopl
die
everi
day
plasmodium
falciparum
infect
two
factor
larg
respons
decrement
increas
deploy
insecticidetr
bednet
increas
avail
highli
effect
artemisinin
combin
treatment
effort
erad
malaria
face
mani
challeng
includ
develop
pyrethroid
resist
anophel
mosquito
emerg
artemisinin
resist
p
falciparum
southeast
asia
white
et
al
one
drive
forc
appear
resist
exposur
parasit
popul
artemisinin
monotherapi
mani
year
phenomenon
resurfac
need
altern
therapeut
malaria
first
describ
antimalari
scorpion
peptid
scorpin
peptid
three
disulfid
bridg
isol
venom
scorpion
p
imper
cond
et
al
scorpin
show
potent
inhibitori
effect
two
key
stage
plasmodium
berghei
develop
although
p
berghei
affect
human
function
rodent
model
malaria
sinc
goe
stage
develop
p
falciparum
infect
gametocyt
mosquito
bite
scorpin
abl
inhibit
develop
p
berghei
ookinet
median
effect
dose
ed
mm
gamet
ed
mm
stage
parasit
develop
also
worth
note
scorpin
one
first
antimalari
peptid
found
way
recent
promis
technolog
antimalari
weapon
transgen
entomopathogen
fungu
metarhizium
anisoplia
engin
express
scorpin
abl
block
transmiss
plasmodium
mosquito
advanc
infect
fang
et
al
two
report
scorpionderiv
ndbp
antimalari
activ
avail
first
one
clone
cdna
librari
scorpion
mesobuthu
eupeu
venom
gland
identifi
encod
ndbp
though
relat
term
structur
sequenc
synthet
peptid
abl
inhibit
develop
p
berghei
ookinet
concentr
rang
mm
moreov
abl
actual
kill
intraerythrocyt
p
falciparum
concentr
mm
significantli
reduc
parasit
densiti
h
posttreat
complet
elimin
parasit
erythrocyt
h
remark
select
plasmodium
detect
toxic
bacteria
fungi
concentr
use
also
hemolyt
effect
mous
erythrocyt
regist
even
mm
concentr
gao
et
al
undoubtedli
strong
candid
antimalari
therapi
report
involv
abovement
amp
deriv
vejovin
hadrurin
display
antibacteri
activ
antimalari
activ
test
result
show
design
variant
inhibit
format
ookinet
p
berghei
mm
doubl
percentag
concentr
increas
mm
sanchezvasquez
et
al
newli
emerg
viral
infect
repres
major
threat
human
health
tradit
vaccin
develop
extrem
effect
strategi
protect
specif
viral
infect
problem
function
vaccin
produc
suffici
quantiti
emerg
viru
avail
vaccin
manufactur
manufactur
process
take
preciou
time
impli
popul
protect
specif
product
length
time
addit
newli
emerg
virus
frequent
exhibit
gene
rearrang
individu
viral
strain
must
first
identifi
character
sinc
unfortun
often
vaccin
particular
infecti
strain
protect
rearrang
one
burk
fish
situat
highlight
relev
develop
gener
antivir
therapeut
scorpion
peptid
display
effect
antivir
peptid
avp
first
report
one
discov
cdna
librari
venom
gland
scorpion
heterometru
petersii
inhibit
hepat
c
viru
hcv
infect
vitro
ic
mm
roughli
mm
inhibit
amplif
hcv
rna
cell
higher
potenc
ifna
prevent
initi
hcv
infect
directli
interact
viral
particl
rapidli
disrupt
phospholipid
membran
avp
good
candid
develop
therapeut
agent
hepat
c
optim
mention
regard
antimicrobi
activ
besid
also
demonstr
antivir
activ
measl
viru
ec
mm
sar
coronaviru
ec
mm
influenza
viru
subtyp
ec
mm
paradox
origin
peptid
mucroporin
show
antivir
activ
three
virus
discoveri
antivir
activ
indic
cation
peptid
scorpion
venom
could
repres
good
candid
develop
multifunct
antivir
agent
alreadi
mention
scorpion
venom
peptid
deriv
identifi
potent
peptid
ec
valu
mm
show
low
cytotox
host
cell
abl
inhibit
member
standard
refer
panel
subtyp
b
pseudotyp
virus
pv
regardless
tropism
roughli
mm
almost
complet
inhibit
viral
replic
cellfre
cellassoci
replicationcompet
activ
correl
direct
interact
envelop
demonstr
avp
rapidli
directli
disrupt
viral
membran
studi
parent
peptid
also
shown
display
activ
though
lesser
extent
peptid
deriv
cdna
librari
scorpion
chaerilu
tryznai
proven
inhibit
hcv
infect
directli
inactiv
infecti
viral
particl
howev
abl
suppress
establish
infect
due
low
bioavail
infect
cell
base
sequenc
two
new
histidinerich
peptid
design
aim
enhanc
cellular
uptak
improv
intracellular
distribut
mutat
peptid
significantli
suppress
establish
hcv
infect
cellular
level
show
even
lower
cytotox
hemolyt
activ
parent
peptid
effect
design
strategi
enhanc
bioavail
peptid
drug
could
also
appli
amp
avp
hong
et
al
recent
two
venom
peptid
scorpion
h
petersii
identifi
effect
inhibitori
effect
herp
simplex
viru
type
infect
vitro
peptid
exhibit
potent
viruscid
activ
ec
mm
mm
respect
result
destruct
viral
morpholog
also
show
effect
inhibitori
effect
ad
differ
stage
life
cycl
attach
entri
post
entri
mean
peptid
abl
enter
host
cell
reduc
intracellular
viral
infect
also
good
candid
develop
antivir
drug
bradykinin
physiolog
pharmacolog
activ
peptid
kinin
group
protein
increas
blood
vessel
vasodil
capillari
permeabl
therefor
caus
arteri
blood
pressur
fall
substrat
angiotensinconvert
enzym
ace
proteolyt
enzym
inactiv
bradykinin
ace
inhibitor
therefor
valuabl
tool
treatment
hypertens
discoveri
bradykininpotenti
peptid
bpp
led
develop
captopril
ace
inhibitor
deriv
peptid
found
venom
lancehead
viper
bothrop
jararaca
nowaday
million
hypertens
patient
worldwid
treat
ace
inhibitor
camargo
et
al
first
scorpion
peptid
shown
display
bradykininpotenti
activ
peptid
isol
venom
scorpion
tityu
serrulatu
peptid
potenti
contractil
activ
bradykinin
isol
guinea
pig
ileum
inhibit
hydrolysi
bradykinin
angiotensinconvert
enzym
also
increas
depressor
effect
bradykinin
arteri
blood
pressur
rat
model
ferreira
et
al
peptid
k
isol
venom
scorpion
buthu
occitanu
abl
potenti
bradykinin
effect
isol
guinea
pig
ileum
well
isol
rat
uteru
peptid
also
strongli
potenti
depressor
effect
bradykinin
arteri
blood
pressur
rat
peptid
k
inhibit
ace
proteolys
enzym
meki
et
al
interest
ctermin
region
bmkbpp
amp
peptid
mention
show
signific
sequenc
similar
peptid
k
inde
bmkbpp
ctermin
fragment
bmkbppc
display
bradykininpotenti
activ
although
less
potent
peptid
concentr
nm
bmkbpp
bmkbppc
induc
signific
shift
doseerespons
curv
muscular
contract
induc
bradykinin
bmkbppc
activ
whole
peptid
suggest
bmkbpp
bmkbppc
bradykinin
potenti
activ
activ
bmkbppc
stronger
bmkbpp
zeng
et
al
worth
mention
scorpion
peptid
potenti
bradykinin
mechan
differ
ace
inhibit
seem
case
serrulatu
hypotensin
tshpt
tshpti
synthet
peptid
compris
cterminu
tshpti
abl
potenti
hypotens
effect
bradykinin
normotens
rat
relev
hypotens
effect
independ
bradykinin
also
observ
tshpti
tshpti
two
peptid
abl
induc
endotheliumdepend
vasorelax
aortic
ring
rat
process
also
depend
nitric
oxid
releas
hypotensin
inhibit
ace
mechan
probabl
improv
endotheli
function
might
relev
blood
pressur
control
deserv
deepli
studi
veranobraga
et
al
voltageg
k
channel
kv
propos
target
immunosupress
k
channel
blocker
inhibit
cell
prolifer
secret
decoursey
et
al
find
subsequ
confirm
koo
et
al
found
margatoxin
peptid
isol
centruroid
margaritatu
scorpion
venom
suppress
delayedtyp
hypersensit
guinea
pig
provid
evid
blockad
inhibit
immun
respons
vivo
koo
et
al
last
decad
sever
compound
block
channel
shown
prevent
delayedtyp
hypersensit
reaction
improv
symptom
variou
experiment
anim
model
autoimmun
diseas
beeton
et
al
beeton
et
al
beeton
et
al
valverd
et
al
mani
toxin
peptid
target
channel
identifi
good
drug
candid
kd
rang
picomolar
micromolar
valu
chandi
et
al
panyi
et
al
amino
acid
peptid
isol
venom
scorpion
v
mexicanu
smithi
inhibit
channel
human
lymphocyt
kd
pm
exhibit
least
select
ion
channel
assay
applic
picomolar
concentr
inhibit
prolifer
ca
signal
human
cell
vitro
reduc
delayedtyp
hypersensit
reaction
rat
vivo
without
signific
side
effect
involv
gener
immunosuppress
characterist
mention
confer
therapeut
potenti
sever
tcell
mediat
autoimmun
diseas
includ
multipl
sclerosi
diabet
rheumatoid
arthriti
psoriasi
among
immunolog
diseas
scorpion
toxin
serv
structur
templat
use
bioengin
novel
molecular
therapeut
treatment
tcell
mediat
autoimmun
diseas
bioengin
synthet
toxin
base
templat
sequenc
peptid
isol
orthochiru
scrobiculosu
scorpion
venom
toxin
display
increas
affin
approxim
five
time
greater
nativ
peptid
mouhat
et
al
anoth
potent
highli
select
inhibitor
peptid
ic
pm
design
use
structur
bmktx
templat
bmktx
peptid
isol
venom
scorpion
martensii
karsch
renisio
et
al
three
nonn
mutat
engin
increas
affin
nativ
bmktx
kd
nm
han
et
al
anoth
exampl
synthet
toxin
design
use
scorpion
toxin
structur
templat
design
identifi
use
phage
display
librari
de
novo
protein
use
aktx
scaffold
scorpion
toxin
sequenc
known
predict
bind
potassium
channel
highli
specif
takac
et
al
bioengin
scorpion
peptid
repres
valuabl
area
research
potenti
tool
bioactiv
scaffold
develop
novel
drug
use
treatment
sever
patholog
potassium
channel
involv
serrulatu
venom
tsv
abl
activ
complement
system
evidenc
decreas
serum
lytic
activ
activ
factor
b
induct
leukocyt
chemotaxi
bertazzi
et
al
case
sever
scorpion
envenom
system
inflammatori
respons
trigger
releas
inflammatori
cytokin
contribut
immunolog
imbal
multipl
organ
dysfunct
death
magalha
et
al
petricevich
high
level
proinflammatori
antiinflammatori
cytokin
human
serum
report
scorpion
envenom
revis
petricevich
scorpion
venom
also
induc
increas
neutrophil
count
blood
simultan
reduct
matur
neutrophil
count
bone
marrow
rat
blood
neutrophilia
consequ
mobil
neutrophil
bone
marrow
turn
depend
activ
plateletactiv
factor
receptor
borg
et
al
studi
perform
serrulatu
venom
andor
major
toxin
show
inmunomodulatori
activ
macrophag
high
level
tumor
necrosi
factor
tnf
interleukin
il
observ
supernat
macrophag
mice
expos
serrulatu
venom
major
toxin
fialho
et
al
petricevich
et
al
way
increas
level
observ
sera
mice
expos
centruroid
noxiu
scorpion
venom
petricevich
depend
concentr
use
tsv
toxin
toxin
stimul
product
nitric
oxid
tnfa
cell
toxin
alon
stimul
product
suggest
antiinflammatori
activ
find
import
basic
understand
mechan
involv
macrophag
activ
follow
scorpion
envenom
zoccal
et
al
use
knockout
mice
demonstr
tsv
interact
tolllik
receptor
tlr
cell
surfac
receptor
cooper
interact
recruit
myeloid
differenti
factor
activ
activ
protein
nfkb
pathway
similarli
induc
tnfa
product
manner
depend
although
signal
occur
mainli
nfkb
activ
zoccal
et
al
data
mention
indic
scorpion
venom
import
immunomodulatori
effect
macrophag
give
us
import
inform
understand
scorpion
envenom
mechan
involv
macrophag
activ
follow
envenom
inform
widen
research
field
scorpion
venom
use
biotechnolog
tool
treat
immunemedi
diseas
report
ndbp
found
scorpion
venom
parabutoporin
opistoporin
addit
antibacteri
antifung
activ
also
present
immunomodul
activ
peptid
micromolar
concentr
abl
interact
cell
membran
form
pore
thu
exercis
antimicrobi
antifung
hemolyt
activ
howev
lower
concentr
peptid
activ
chemotaxi
exocytosi
inhibit
product
superoxid
granulocyt
parabutoporin
isol
venom
scorpion
p
schlechteri
opistoptoporin
venom
scorpion
carinatu
amphipat
ahel
peptid
amino
acid
respect
peptid
capabl
induc
revers
releas
ca
intracellular
store
ca
granulocytelik
cell
releas
calcium
sensit
pertussi
toxin
indic
releas
ca
involv
g
protein
moerman
et
al
shown
parabutoporin
inhibit
activ
nadph
oxidas
act
competit
inhibitor
protein
kinas
b
akt
thu
contribut
declin
superoxid
product
human
neutrophil
remijsen
et
al
parabutoporin
delay
neutrophil
apoptosi
via
lipid
raftdepend
activ
akt
remijsen
et
al
shown
parabutoporin
also
stimul
neutrophil
motil
activ
pertussi
toxin
sensit
signal
pathway
upregul
gtp
bound
level
possibl
interact
g
protein
propos
earlier
remijsen
et
al
previous
mention
bmkbpp
besid
antimicrobi
antifung
activ
micromolar
concentr
also
inhibit
superoxid
product
granulocyt
cell
submicromolar
concentr
zeng
et
al
parabutoporin
opistoporin
bmkbpp
long
chain
multifunct
peptid
classifi
principl
pharmacolog
activ
sequenc
similar
peptid
length
togeth
hadrurin
torreslario
et
al
miyashita
et
al
vejovin
hernandezapont
et
al
mauriporin
almaaytah
et
al
last
peptid
might
function
properti
parabutoporin
opistoporin
bmkbpp
almaaytah
albala
multifunct
peptid
antimicrobi
immuneregulatori
activ
provid
interest
tool
pharmaceut
design
accord
estim
intern
agenc
research
cancer
iarc
million
new
cancer
case
million
cancer
death
worldwid
number
million
respect
cancer
rise
global
mainli
age
growth
world
popul
ferlay
et
al
last
decad
seen
signific
progress
diagnosi
therapeut
approach
cancer
treatment
despit
favor
advanc
classic
method
avail
today
surgeri
radiat
chemotherapi
still
show
rel
low
success
rate
high
risk
reoccurr
lack
adequ
select
tumor
cell
therefor
unspecif
target
healthi
cell
mani
deleteri
side
effect
serious
limit
effect
avail
chemotherapeut
morgan
et
al
search
specif
select
anticanc
drug
either
design
de
novo
deriv
natur
compound
remain
activ
field
forese
futur
anticanc
peptid
repres
import
resourc
design
tumortarget
drug
could
allow
tackl
cancer
develop
process
differ
angl
small
molecul
display
effici
tissu
penetr
uptak
heterogen
cancer
cell
could
act
tumor
directli
intrins
activ
synerg
exist
chemotherapeut
function
carrier
vehicl
drug
lower
select
bioavail
gaspar
et
al
scorpion
venom
compon
promis
sourc
biolog
activ
molecul
potenti
fight
cancer
scorpion
protein
peptid
shown
vitro
vivo
effect
cancer
cell
one
even
reach
phase
phase
ii
clinic
trial
heinen
da
veiga
chlorotoxin
cltx
uniprotkb
peptid
contain
amino
acid
disulfid
bond
purifi
venom
scorpion
leiuru
quinquestriatu
debin
et
al
possess
singl
tyrosin
residu
avail
radioiodin
solut
structur
determin
nmr
spectroscopi
consist
small
threestrand
antiparallel
bsheet
crosslink
ahelix
three
disulfid
bond
fourth
one
link
small
ntermin
beta
strand
rest
molecul
character
peptid
knottin
lippen
et
al
earliest
studi
show
cltx
abl
block
smallconduct
cl
channel
deriv
epitheli
cell
debin
et
al
bind
chlorid
channel
specif
express
human
astrocytoma
glioma
cell
also
shown
ullrich
et
al
ullrich
et
al
ullrich
sontheim
experi
allow
identif
voltageactiv
chlorid
channel
present
astrocyt
inde
shown
cltx
inhibit
chlorid
channel
bind
deshan
et
al
mamelak
jacobi
cltx
caus
endocytosi
subtyp
cl
channel
upregul
glioma
membran
deplet
cellsurfac
clchannel
cltx
effect
block
migrat
sttgi
human
glioma
cell
ion
channel
deplet
alon
abl
fulli
block
glioma
cell
invas
lui
et
al
complex
interact
shown
specif
neuroectoderm
cell
glioma
tumor
cltx
bind
normal
human
tissu
includ
neuron
cell
debin
et
al
lyon
et
al
recent
shown
cltxmodifi
liposom
capabl
significantli
inhibit
breast
tumor
growth
aggress
metastat
breast
cancer
cell
line
deriv
balbc
mous
mammari
tumor
highli
express
well
increas
antimetastasi
effect
qin
et
al
differ
vehicl
nanocapsul
exhibit
monomer
fusion
chlorotoxin
amino
terminu
human
iggfc
mcltxfc
intern
inhibit
migrat
pancreat
cancer
cell
elghlban
et
al
mani
group
work
elabor
nanoparticl
conjug
chlorotoxin
specif
glioma
either
accesstreat
cancer
monitorvisu
tumor
growth
recent
revis
present
fu
et
al
cltx
also
use
vivo
vitro
improv
anticanc
activ
chemotherapi
drug
doxorubicin
anthracyclin
antibiot
use
reduc
inhibit
cancer
cell
growth
xiang
et
al
cltx
use
ligand
direct
effect
stabl
nucleic
acid
lipid
particl
snalp
transport
small
interf
rna
sirna
antisens
oligonucleotid
aso
glioblastoma
vitro
vivo
costa
et
al
transmolecular
industri
develop
synthet
cltx
commerci
equival
approv
fda
clinic
test
besid
antitumor
activ
present
antiangiogen
properti
abl
inhibit
angiogenesi
vitro
vivo
stimul
mani
factor
potenti
antiangiogen
effect
bevacizumab
monoclon
antibodi
attach
vascular
endotheli
growth
factor
vegf
inhibit
establish
new
blood
vessel
feed
tumor
effect
inhibit
neovascular
induc
basic
fibroblast
growth
factor
bfgf
tumor
necrosi
factor
tnfa
wherea
bevacizumab
jacobi
et
al
addit
inhibit
glioma
cell
growth
invas
angiogenesi
vivo
cltx
abl
cross
bloodebrain
barrier
bbb
hockaday
et
al
uniqu
properti
made
cltx
ideal
candid
clinic
trial
glioma
phase
studi
iodin
intracavitarli
administr
patient
recurr
malign
glioma
radiolabel
present
increas
lifetim
tumor
area
compar
normal
brain
specif
surgic
caviti
grade
toxic
well
toler
besid
patient
nt
show
progress
tumor
month
mamelak
et
al
consequ
phase
ii
studi
initi
unit
state
enrol
patient
center
present
recurr
glioma
result
show
surviv
improv
made
known
annual
meet
neurooncolog
societi
shen
et
al
wide
notic
medic
newspap
phase
iii
clinic
trial
also
show
import
imag
tool
determin
extent
neoplast
growth
hockaday
et
al
bioconjug
consist
cltx
fluoresc
compound
success
use
demarc
cancer
cell
surround
normal
cell
patient
increas
chanc
remov
cancer
cell
without
damag
healthi
cell
stroud
et
al
chlorotoxin
specif
agent
diagnosi
treatment
glioma
bbb
permeabl
nontox
nonimmunogen
consid
success
target
drug
glioblastoma
give
hope
cancer
cure
mrugala
et
al
cdna
sequenc
encod
four
disulfid
bridg
short
chain
toxin
name
bmkct
clone
venom
gland
martensii
karsch
show
ident
chlorotoxin
isol
l
quinquestriatu
yang
et
al
recombin
bmkct
rbmkct
revers
inhibit
chlorid
current
singl
glioma
cell
yang
et
al
well
human
glioma
cell
also
prolifer
inhibit
toxin
normal
astrocyt
affect
fu
et
al
rbmkct
intraperitoneali
administ
normal
mice
histolog
analysi
show
damag
brain
leg
muscl
cardiac
muscl
fu
et
al
ibmkct
specif
conjug
glioma
cell
inhibit
cell
growth
vitro
recombin
gstbmkct
inhibit
growth
metastasi
glioma
cell
vivo
rat
ilabel
rgstbmkct
target
specif
glioma
situ
fan
et
al
combin
therapi
bmkct
licl
synergist
inhibit
migrat
invas
prolifer
glioma
cell
accompani
diminish
activ
fu
et
al
recent
deliveri
system
base
recombin
replicationdefect
adenoviru
ad
construct
serv
vehicl
transport
bmkct
gene
glioma
cell
author
show
adbmkct
significantli
inhibit
tumor
prolifer
mice
timedepend
manner
cdna
librari
made
venom
gland
martensii
karsch
sequenc
bmk
agap
identifi
possess
high
ident
sodium
channel
modul
atoxin
zeng
et
al
later
shown
bmk
agap
present
analges
antitumor
activ
liu
et
al
lui
et
al
zhao
et
al
bmk
agap
analges
activ
verifi
hotplat
mous
twist
assay
liu
et
al
antitumor
activ
shown
vivo
fibrosarcoma
ehrlich
ascit
tumor
model
bmk
agap
increas
surviv
period
decreas
tumor
size
mgkg
mous
bodi
weight
liu
et
al
recombin
rbmk
agap
ragap
inhibit
prolifer
glioma
cell
lead
cell
cycl
arrest
phase
suppress
protein
relat
cell
cycl
regul
cell
growth
recent
new
peptid
hold
ident
bmk
agap
isol
venom
scorpion
speci
also
present
dualfunct
analges
antitumor
activ
name
bmk
shao
et
al
peptid
name
margatoxin
mgtx
isol
venom
c
margaritatu
inhibit
ntype
current
human
tlymphocyt
k
v
channel
signific
effect
k
v
k
v
isk
slowli
activ
k
channel
clone
smooth
muscl
heart
maxik
channel
delay
rectifi
mous
pancreat
b
cell
garciacalvo
et
al
mgtx
inhibit
cell
prolifer
human
lung
adenocarcinoma
cell
line
lead
signific
increment
phase
decreas
phase
mechan
involv
accumul
decreas
cyclin
jang
et
al
author
show
vivo
tumor
volum
reduct
mice
inject
mgtx
iberiotoxin
ibtx
acid
peptid
present
sequenc
ident
charybdotoxin
chtx
purifi
venom
mesobuthu
tumulu
show
select
blocker
high
conduct
calciumactiv
maxik
also
known
bkchannel
potassium
channel
galvez
et
al
human
astrocytoma
cell
inhibit
bkchannel
ibtx
abolish
k
channel
induc
prolifer
basrai
et
al
inhibit
bkchannel
ibtx
arrest
glioma
cell
phase
induc
cell
death
weaver
et
al
ibtx
inhibit
growth
hormon
insensit
prostat
cancer
cell
line
amplif
function
overexpress
gene
encod
poreform
asubunit
maxik
channel
bloch
et
al
charybdotoxin
chtx
purifi
venom
l
quinquestriatu
hebraeu
amino
acid
residu
inhibit
calciumactiv
potassium
channel
gimenezgallego
et
al
chtx
select
ca
activ
k
channel
schweitz
et
al
chtx
inhibit
migrat
fibroblast
human
melanoma
cell
possibl
reduc
electrochem
drive
forc
ca
entri
k
channel
blockag
schwab
et
al
whole
venom
heterometru
bengalensi
present
antiprolif
apoptogen
activ
human
leukem
cell
line
da
gupta
et
al
later
high
molecular
weight
protein
kda
identifi
name
bengalin
anticanc
activ
human
leukem
cell
line
induct
apoptosi
predominantli
mediat
mitochondri
pathway
particip
pro
antiapoptot
protein
signific
death
normal
human
lymphocyt
recent
work
show
cell
death
induc
bengalin
occur
altern
pathway
apoptosi
could
autophag
natur
da
gupta
et
al
bengalin
also
present
antiosteoporosi
activ
capac
restor
bone
miner
cardiotox
neurotox
demonstr
vivo
experi
haldar
et
al
two
non
disulphidebridg
amid
peptid
isol
venom
brazilian
yellow
scorpion
serrulatu
present
antimicrobi
anticanc
activ
guo
et
al
similar
howev
higher
helic
content
hydrophob
moment
compar
explain
diverg
antimicrobi
activ
synthet
analog
increas
cation
reduc
antimicrobi
activ
enhanc
anticanc
cell
activ
evalu
oral
squamou
carcinoma
lung
adenocarcinoma
breast
carcinoma
prostat
carcinoma
glioblastoma
cancer
cell
guo
et
al
neopladin
purifi
venom
tityu
discrepan
consist
protein
da
da
molecular
mass
respect
present
apoptot
activ
human
breast
carcinoma
cell
activ
fa
signal
induct
fasl
express
dsuze
et
al
hyaluronidas
enzym
purifi
martensi
karsh
molecular
mass
da
capac
digest
wide
rang
hyaluronan
fragment
feng
et
al
known
hyaluronan
upregul
breast
cancer
relat
aggress
differ
tumor
anttila
et
al
remov
hyaluronan
breast
cancer
cell
line
led
downregul
variant
protein
highli
express
cancer
cell
feng
et
al
maurocalcin
mca
amino
acid
residu
peptid
isol
scorpio
mauru
palmatu
act
ryanodin
receptor
ryr
fajloun
et
al
imperatoxin
iptxa
p
imper
first
scorpion
toxin
capac
bind
ryr
high
affin
specif
valdivia
et
al
share
structur
ident
segment
iieiii
loop
skelet
muscl
dihydropyridin
receptor
hat
propos
act
activ
fajloun
et
al
known
scorpion
calcin
capac
act
ryr
togeth
mani
peptid
abl
transloc
across
plasma
membran
within
second
minut
term
cellpenetr
peptid
cpp
howl
et
al
instanc
maurocalcin
effici
use
intracellular
deliveri
agent
doxorubicin
dox
lowand
highinvas
breast
carcinoma
mdamb
cell
doxresist
doxsensit
cell
line
respect
vitro
doxresist
cell
line
coupl
dox
maurocalcin
allow
overcom
drug
resist
aroui
et
al
mani
mca
analog
low
toxic
shorter
length
design
abil
drive
differ
compound
intracellular
space
prove
cond
et
al
tisseyr
et
al
review
poillot
de
waard
among
possibl
applic
diagnost
tool
base
coupl
mca
dye
nanoparticl
jayagop
et
al
theragnost
applic
mean
coupl
mca
radioact
materi
tisseyr
et
al
directlyact
antitumor
therapeut
diagnost
tag
adjuv
carrier
relev
moieti
scorpionderiv
molecul
shown
potenti
tool
fight
cancer
clear
larg
divers
scorpion
venom
compon
repres
treasur
natur
compound
could
eventu
find
way
pharmaceut
potenti
applic
newli
describ
molecul
probabl
continu
fuel
scorpion
venom
research
forese
futur
tini
fraction
whole
univers
venom
compon
expect
exist
differ
speci
character
thu
far
possibl
seem
endless
author
declar
manuscript
compli
elsevi
ethic
guidelin
journal
public
